Evidence map›Paper›PMID 41427161›Full record

ArticleThe Pan African medical journal2025

Epidemiological, clinical and outcomes of pleural tuberculosis: insights from a 646-patient cohort in the province of Khémisset, Morocco.

Ismail Ouhammou, Hinde Hami, Arabi Rida, Mezouara Mounia, Ouassima Erefai, Driss Hmouni

Abstract read
In one paragraph

Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ismail OuhammouLaboratory of Natural Resources and Sustainable Development, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco.
Hinde HamiLaboratory of Biology and Health, Faculty of Science, Ibn Tofail University, Kenitra, Morocco.
Arabi RidaLaboratory of Natural Resources and Sustainable Development, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco.
Mezouara MouniaLaboratory of Natural Resources and Sustainable Development, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco.
Ouassima ErefaiLaboratory of Biology and Health, Faculty of Science, Ibn Tofail University, Kenitra, Morocco.
Driss HmouniLaboratory of Natural Resources and Sustainable Development, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: pleural tuberculosis, the second most common extrapulmonary manifestation after lymph node involvement, poses a considerable diagnostic and therapeutic challenge. This study examines the epidemiological, clinical, biological, and therapeutic features of pleural tuberculosis cases in Khémisset, a province in Morocco's Rabat-Sale-Kenitra region, which reports the country's second-highest tuberculosis incidence. Methods: this retrospective study examined the medical records of patients diagnosed with pleural tuberculosis at the Khémisset Diagnostic Center for Tuberculosis and Respiratory Diseases between 2016 and 2020. A multivariate logistic regression analysis was performed to identify the determinants associated with treatment failure. Results: over the five-year study period, 646 cases of pleural tuberculosis were recorded, representing 19.8% and 48.8% of all tuberculosis and extrapulmonary tuberculosis cases in our cohort, respectively. The mean patient age was 42 years (standard deviation 22.2), with a male predominance (59.4%, male-to-female ratio of 1.46). A bimodal age distribution was observed, peaking in young adults (20-44 years, 39.6%) and older individuals (>55 years, 34.6%). Geographically, cases were nearly evenly distributed between urban (49.7%) and rural (50.3%) areas. The majority (95.2%) were new pleural tuberculosis cases, while 4.2% had concurrent extrapulmonary or pulmonary tuberculosis involvement. Notably, HIV screening was performed in only 31.1% of cases, all of which yielded negative results. Treatment outcomes were favourable, with a therapeutic success rate of 84.4% and a mortality rate of 8%. Multivariate logistic regression analysis revealed the presence of an association of clinical forms significantly linked to an increased risk of failure. The adjusted model indicates an OR of 2.45 (95% CI: 1.02 - 5.88; P = 0.045). Conclusion: pleural tuberculosis accounts for 1 in 5 tuberculosis cases locally. Our study reveals that, despite high treatment success rates, a significant proportion of patients with pleural tuberculosis fail treatment, particularly those with mixed symptoms, especially if they have a combination of other forms of tuberculosis, which increases the risk of failure.

Indexed as

Antitubercular AgentsTuberculosis, PleuralAdolescentAdultAgedAge DistributionChildChild, PreschoolCohort StudiesFemaleHIV InfectionsHumansIncidenceLogistic ModelsMaleMiddle AgedAntitubercular AgentsepidemiologyKhémissetMoroccoPleural tuberculosis

Identifiers

PMID41427161
PMCPMC12716332

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.